FDA Home | Search FDA Site | A-Z Index | Contact FDA

Vaccines and Related Biological Products Advisory Committee

Agenda:
The committee will review and discuss the selection of strains to be included in the influenza virus vaccine for the 2003-2004 season and the intramural research program of the Laboratory of Bacterial Polysaccharides, Office of Vaccines Research and Review.

Closed Committee Deliberations: On February 20, 2003, from 3:20 p.m. to 4:30 p.m., the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)).

Procedure:
On February 20, 2003, from 8:30 a.m. to 3:20 p.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by February 4, 2003. Oral presentations from the public will be scheduled between approximately 1 p.m. and 1:30 p.m. and 2:50 p.m. and 3:20 p.m.

Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before February 4, 2003, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.

Contact Person:
Jody G. Sachs or Denise H. Royster, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting.

[See Full FR Notice]